Q32 Bio to Participate in Upcoming September Investor Conferences
Ben Wolff and Trevor Thatcher will join a Jefferies fireside chat and a Lake Street 1:1 meeting, with webcast access for investors.
- On Monday, Palladyne AI announced that CEO Ben Wolff and CFO Trevor Thatcher will participate in two upcoming investor conferences this September.
- The Salt Lake City-based company develops embodied artificial intelligence and collaborative autonomy solutions designed for defense, industrial, and aerospace markets.
- Wolff will participate in a fireside chat at the Jefferies Global Industrials Conference on Wednesday, September 9, hosted by Jefferies analyst Adam Samuelson.
- The following day, Thursday, September 10, both Wolff and Thatcher will attend the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference, known as 'BIG10.'
- Qualified investors can contact their Jefferies and Lake Street representatives to schedule meetings, while media inquiries should be directed to press contact Heath Meyer.
17 Articles
17 Articles
Morgan County Citizen
inovio.comINOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in…
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will…
North Bay Nipissing
Financial PostProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming September 2026 conferences…
BridgeBio to Participate in September Investor Conferences
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate…
Q32 Bio to Participate in Upcoming September Investor Conferences
WALTHAM, Mass., Sept. 1, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will participate…
ParrySound.com
The Hamilton SpectatorSatellos to Participate in Upcoming Investor Conferences
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences in September.
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
